ArticleFrontiers in oncology2026

UBTD1: a prognostic and immune biomarker validated in thyroid cancer and pan-cancer analysis.

Baoguo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.